Patents by Inventor Melissa M. Cunningham

Melissa M. Cunningham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligonucleotides for amplifying nucleic acid
    Patent number: 8586724
    Abstract: Amplification oligonucleotides for use in amplifying a sequence contained in nucleic acid derived from Chlamydophila pneumoniae.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: November 19, 2013
    Assignee: Gen-Probe Incorporated
    Inventor: Melissa M. Cunningham
  • OLIGONUCLEOTIDES FOR AMPLIFYING CHLAMYDOPHILA PNEUMONIAE NUCLEIC ACID
    Publication number: 20120202213
    Abstract: Amplification oligonucleotides for use in amplifying a sequence contained in nucleic acid derived from Chlamydophila pneumoniae.
    Type: Application
    Filed: April 23, 2012
    Publication date: August 9, 2012
    Applicant: GEN-PROBE INCORPORATED
    Inventor: Melissa M. CUNNINGHAM
  • Oligonucleotides for amplifying nucleic acid
    Patent number: 8188258
    Abstract: Oligonucleotides for use in determining the presence of Chlamydophila pneumoniae in a test sample. The oligonucleotides are incorporated into detection probes, capture probes, and amplification oligonucleotides, and can be used in various combinations thereof.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: May 29, 2012
    Assignee: Gen-Probe Incorporated
    Inventor: Melissa M. Cunningham
  • Compositions and methods for detecting the presence of in a test sample
    Patent number: 8105779
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Cryptosporidium organisms, and Cryptosporidium parvum organisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: January 31, 2012
    Inventors: Melissa M. Cunningham, Paul D. Stull, William G. Weisburg
  • Compositions and Methods For Detecting The Presence Of Cryptosporidium Parvum In A Test Sample
    Publication number: 20110269133
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Cryptosporidium organisms, and Cryptosporidium parvum organisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Application
    Filed: July 14, 2011
    Publication date: November 3, 2011
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Melissa M. CUNNINGHAM, Paul D. STULL, William G. WEISBURG
  • Compositions and methods for detecting the presence of cryptosporidium organisms in a test sample
    Patent number: 8008017
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Cryptosporidium organisms, and Cryptosporidium parvum organisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: August 30, 2011
    Assignee: Gen-Probe Incorporated
    Inventors: Melissa M. Cunningham, Paul D. Stull, William G. Weisburg
  • OLIGONUCLEOTIDES FOR AMPLIFYING CHLAMYDOPHILA PNEUMONIAE NUCLEIC ACID
    Publication number: 20110091894
    Abstract: Oligonucleotides for use in determining the presence of Chlamydophila pneumoniae in a test sample. The oligonucleotides are incorporated into detection probes, capture probes, and amplification oligonucleotides, and can be used in various combinations thereof.
    Type: Application
    Filed: December 16, 2010
    Publication date: April 21, 2011
    Applicant: GEN-PROBE INCORPORATED
    Inventor: Melissa M. CUNNINGHAM
  • Compositions and methods for determining the presence of in a test sample
    Patent number: 7858347
    Abstract: Oligonucleotides for use in determining the presence of Chlamydophila pneumoniae in a test sample. The oligonucleotides are incorporated into detection probes, capture probes, and amplification oligonucleotides, and can be used in various combinations thereof.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: December 28, 2010
    Assignee: Gen-Probe Incorporated
    Inventor: Melissa M. Cunningham
  • Compositions and Methods For Detecting The Presence Of Cryptosporidium Organisms In A Test Sample
    Publication number: 20100003693
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Cryptosporidium organisms, and Cryptosporidium parvum organisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Application
    Filed: September 8, 2009
    Publication date: January 7, 2010
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Melissa M. CUNNINGHAM, Paul D. STULL, William G. WEISBURG
  • Method for obtaining purified RNA from viable oocysts
    Patent number: 7585631
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Crytosporidium organisms, and Crytosporidium parvum organisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Grant
    Filed: July 25, 2006
    Date of Patent: September 8, 2009
    Assignee: Gen-Probe Incorporated
    Inventors: Melissa M. Cunningham, Paul D. Stull, William G. Weisburg
  • COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF CHLAMYDOPHILA PNEUMONIAE IN A TEST SAMPLE
    Publication number: 20090220981
    Abstract: Oligonucleotides for use in determining the presence of Chlamydophila pneumoniae in a test sample. The oligonucleotides are incorporated into detection probes, capture probes, and amplification oligonucleotides, and can be used in various combinations thereof.
    Type: Application
    Filed: February 2, 2009
    Publication date: September 3, 2009
    Applicant: GEN-PROBE INCORPORATED
    Inventor: Melissa M. CUNNINGHAM
  • Compositions and methods for determining the presence of in a test sample
    Patent number: 7498137
    Abstract: The present invention relates to oligonucleotides useful for determining the presence of Chlamydophila pneumoniae in a test sample. The oligonucleotides of the present invention may be incorporated into detection probes, capture probes and amplification oligonucleotides, and used in various combinations thereof.
    Type: Grant
    Filed: June 6, 2006
    Date of Patent: March 3, 2009
    Assignee: Gen-Probe Incorporated
    Inventor: Melissa M. Cunningham
  • Probes, compositions and kits for determining the presence of in a test sample
    Patent number: 7345155
    Abstract: The present invention relates to oligonucleotides useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium in a test sample. The oligonucleotides of the present invention may be incorporated into hybridization assay probes, capture probes and amplification primers, and used in various combinations thereof.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: March 18, 2008
    Assignee: Gen-Probe Incorporated
    Inventors: Melissa M. Cunningham, James P. Light, II
  • Probes, compositions and kits for determining the presence of in a test sample
    Patent number: 7214780
    Abstract: The present invention relates to oligonucleotides useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium in a test sample. The oligonucleotides of the present invention may be incorporated into hybridization assay probes, capture probes and amplification primers, and used in various combinations thereof.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: May 8, 2007
    Assignee: Gen-Probe Incorporated
    Inventors: Melissa M. Cunningham, James P. Light, II
  • Compositions, methods and kits for determining the presence of organisms in a test sample
    Patent number: 7081527
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Cryptosporidium organisms, and Cryptosporidium parvum organisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Grant
    Filed: September 11, 2001
    Date of Patent: July 25, 2006
    Assignee: Gen-Probe Incorporated
    Inventors: Melissa M. Cunningham, Paul D. Stull, William G. Weisburg
  • Compositions, methods and kits for determining the presence of Mycoplasma genitalium in a test sample
    Publication number: 20030203376
    Abstract: The present invention relates to oligonucleotides useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium in a test sample. The oligonucleotides of the present invention may be incorporated into hybridization assay probes, capture probes and amplification primers, and used in various combinations thereof.
    Type: Application
    Filed: October 31, 2002
    Publication date: October 30, 2003
    Inventors: Melissa M. Cunningham, James P. Light
  • Compositions, methods and kits for determining the presence of Mycoplasma pneumoniae in a test sample
    Publication number: 20030194723
    Abstract: The present invention relates to oligonucleotides useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium in a test sample. The oligonucleotides of the present invention may be incorporated into hybridization assay probes, capture probes and amplification primers, and used in various combinations thereof.
    Type: Application
    Filed: October 31, 2002
    Publication date: October 16, 2003
    Inventors: Melissa M. Cunningham, James P. Light
  • Compositions, methods and kits for determining the presence of cryptosporidium parvum organisms in a test sample
    Publication number: 20020146717
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Cryptosporidium organisms, and Cryptosporidium parvum organisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Application
    Filed: September 11, 2001
    Publication date: October 10, 2002
    Inventors: Melissa M. Cunningham, Paul D. Stull, William G. Weisburg
  • Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
    Publication number: 20020055116
    Abstract: The present invention describes novel oligonucleotides targeted to nucleic acid sequences derived from Cryptosporidium organisms, and Cryptosporidium parvumorganisms in particular, which are useful for determining the presence of Cryptosporidium organisms in a test sample. The oligonucleotides of the present invention include hybridization assay probes, helper probes and amplification primers. The present invention further describes a novel method for obtaining purified ribonucleic acid from viable oocysts.
    Type: Application
    Filed: September 11, 2001
    Publication date: May 9, 2002
    Inventors: Melissa M. Cunningham, Paul D. Stull, William G. Weisburg